Now I see why the Anp Board decided to flip the DMD trial in Europe for a shorter time frame trial
CG was responsible to change tack ...
Like I said before a few here were against the change !
Now we can take confidence that the FDA is prepared to take Phase 2B data as acceptable for a NDA .
The elected Board are doing a wonderful job and are streaks ahead more than we can imagine .$$
Be confident in our Board.
For General Information, page-2721
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.8¢ | $49.85K | 497.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 101000 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 282099 | 4 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |